Protein detection and quantification are daily occurrences both in research and diagnostic laboratories. Also, follow-ups of therapeutic treatments and prognoses have grown to rely more and more on ...

Since their inception in 1995, DNA microarrays have become the icon of the genomics revolution. Everyone with any interest has become familiar with the images of precise rows and columns of colored ...

Advances in material science combined with nanofabrication and computational design have led to the discovery of label-free protein microarray techniques. These techniques are of enormous benefit for ...

BOSTON--(BUSINESS WIRE)--Sengenics today announced the commercial launch of the i-Ome® Protein Array Kit. The i-Ome® Protein Array Kit contains slide-based, high density protein microarrays, comprised ...

As protein arrays have become increasingly consistent and reliable, more scientists have begun to incorporate them into their proteomics experiments. Researchers are attracted by the technology’s ...

As illustrated by Dr. Carl Borrebaeck, [4] of Lund University, Sweden, bioarrays may be based on proteins or on affinity reagents. Defined sets of proteins, such as autoantigens, are spotted on ...

Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...

A designed polypeptide scaffold contains a surface immobilization domain and a target capture domain for flexible protein arraying. 'Microarray' might just be the hottest buzzword in biology today.

The sequencing phase of the human genome project is now near completion, but then what? An even harder challenge remains — to identify the structures and functions of all proteins encoded in the ...

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease. Dr Alyssa Barry from the Walter and Eliza Hall ...

Polymorphism BCL2 c(-717)a and prognosis in diffuse large B-cell lymphoma patients. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...

BOSTON--(BUSINESS WIRE)--Sengenics announced the launch of a new autoantibody profiling service – the ‘Pan-Autoimmune Protein Array 1.0’ – to expedite the identification and quantitation of ...